ConductScience.org, home

Paper28813655

Making It Personal: Neoantigen Vaccines in Metastatic Melanoma.

Hellmann MD and 1 other. Immunity, 2017. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. Making It Personal: Neoantigen Vaccines in Metastatic Melanoma. Papers, record 28813655. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28813655

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Making It Personal: Neoantigen Vaccines in Metastatic Melanoma.
PubMed
Journal
Immunity
PubMed
Year
2017
PubMed
Publication types
Journal Article, Comment
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
0.71
iCite
Revised in PubMed
2021-01-02
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hellmann MDMatthew D
2Snyder AAlexandra

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
Cancer VaccinesMajor topic
ImmunotherapyMajor topic
MelanomaMajor topic
Skin NeoplasmsMajor topic
Animals
Autoantigens
Clinical Trials, Phase I as Topic
Humans
Mutation
Neoplasm Metastasis
Vaccines, Subunit

Source PubMed

Download CSV of topics

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment on28678778An immunogenic personal neoantigen vaccine for patients with melanoma.https://conductscience.org/library/papers/28678778PubMed
Comment on28678784Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.https://conductscience.org/library/papers/28678784PubMed

Download CSV of comments and corrections

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
40129944TCR-T cell therapy for solid tumors: challenges and emerging solutions.Front Pharmacol2025https://conductscience.org/library/papers/40129944PubMed
39872522DNA vaccines as promising immuno-therapeutics against cancer: a new insight.Front Immunol2024https://conductscience.org/library/papers/39872522PubMed
38713894Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma.Blood Adv2024https://conductscience.org/library/papers/38713894PubMed
38625508Advances in Therapeutic Cancer Vaccines, Their Obstacles, and Prospects Toward Tumor Immunotherapy.Mol Biotechnol2025https://conductscience.org/library/papers/38625508PubMed
37554274Caveolin-mediated cytosolic delivery of spike nanoparticle enhances antitumor immunity of neoantigen vaccine for hepatocellular carcinoma.Theranostics2023https://conductscience.org/library/papers/37554274PubMed
37294501The future of cancer immunotherapy: DNA vaccines leading the way.Med Oncol2023https://conductscience.org/library/papers/37294501PubMed
35126730Neoantigens and their potential applications in tumor immunotherapy.Oncol Lett2022https://conductscience.org/library/papers/35126730PubMed
35036074Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma.Oncoimmunology2022https://conductscience.org/library/papers/35036074PubMed
34703645Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination.Mol Ther Nucleic Acids2021https://conductscience.org/library/papers/34703645PubMed
32483434Personalized neoantigen vaccination with synthetic long peptides: recent advances and future perspectives.Theranostics2020https://conductscience.org/library/papers/32483434PubMed
32322001The premise of personalized immunotherapy for cancer dormancy.Oncogene2020https://conductscience.org/library/papers/32322001PubMed
32295135Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer.Vaccines (Basel)2020https://conductscience.org/library/papers/32295135PubMed
31979205Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells-An Update.Pharmaceutics2020https://conductscience.org/library/papers/31979205PubMed
31134073Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma.Front Immunol2019https://conductscience.org/library/papers/31134073PubMed
31040852Attacking Tumors From All Sides: Personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity.Front Immunol2019https://conductscience.org/library/papers/31040852PubMed
30953535Cancer DNA vaccines: current preclinical and clinical developments and future perspectives.J Exp Clin Cancer Res2019https://conductscience.org/library/papers/30953535PubMed
30923036Immunotherapy of Melanoma: Facts and Hopes.Clin Cancer Res2019https://conductscience.org/library/papers/30923036PubMed
30218648Stochastic modeling of tumor progression and immune evasion.J Theor Biol2018https://conductscience.org/library/papers/30218648PubMed
30013560Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy.Front Immunol2018https://conductscience.org/library/papers/30013560PubMed
29209575Trial watch: DNA-based vaccines for oncological indications.Oncoimmunology2017https://conductscience.org/library/papers/29209575PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28813655

GET https://conductscience.org/api/papers/v1/28813655/authors